Altimmune Appoints Vipin K. Garg, Ph.D. as its New President and Chief Executive Officer
GAITHERSBURG, Md., Nov. 27, 2018 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics company, today announced the appointment […]